|
Re: About the Monday Presentation
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 08:20AM
|
|
NCT03901469: A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
|
6
|
Zenith Epigenetics
|
Apr 08, 2019 07:40AM
|
|
Re: What Monday Brings?
|
6
|
Zenith Epigenetics
|
Jun 17, 2016 09:36AM
|
|
Re: Trial
|
6
|
Zenith Epigenetics
|
Nov 21, 2019 02:30PM
|
|
Re: While we wait, outside items that may be of interest
|
6
|
Resverlogix Corp.
|
Aug 27, 2017 07:47AM
|
|
Re: Probability of Phase 3 trial success
|
6
|
Resverlogix Corp.
|
Jun 23, 2019 12:26PM
|
|
Re: ... clarification update...
|
6
|
Resverlogix Corp.
|
Jun 11, 2018 03:54PM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Mar 26, 2017 03:01PM
|
|
A lesson on futility analyses from the CETP inhibitors
|
6
|
Resverlogix Corp.
|
May 10, 2017 02:47PM
|
|
Re: Trials and statistics, next steps
|
6
|
Resverlogix Corp.
|
Feb 12, 2020 08:28AM
|
|
Re: Could Apabelalone ever replace statins,....
|
6
|
Resverlogix Corp.
|
May 13, 2019 12:37PM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Sep 29, 2018 01:21PM
|
|
Coronary Artery Calcium Score
|
6
|
Resverlogix Corp.
|
Dec 21, 2018 10:34AM
|
|
Re: So.....? ... just takes one...
|
6
|
Resverlogix Corp.
|
Oct 15, 2017 10:20PM
|
|
Re: Led Gac
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 04:56PM
|
|
Re: tiny volume
|
6
|
Resverlogix Corp.
|
Oct 04, 2018 02:08PM
|
|
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International AD/PD Conference
|
6
|
Resverlogix Corp.
|
Apr 01, 2019 11:08AM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Jan 11, 2018 03:01PM
|
|
Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
6
|
Resverlogix Corp.
|
Aug 14, 2019 08:54AM
|
|
Re: I asked IR today about why no aGFR data....
|
6
|
Resverlogix Corp.
|
Mar 30, 2020 09:55PM
|
